发明名称 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
摘要 The present invention is concerned with compounds of formulathe N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein R<1 >is hydrogen, hydroxy, C1-6alkyl or aryl; R<2 >is hydrogen; optionally substituted C1-12alkyl; C3-7cycloalkyl; C2-8alkenyl, optionally substituted pyrrolidinyl or aryl; R<3 >is hydrogen, optionally substituted C1-6alkyl or aryl; Het is an optionally substituted unsaturated heterocycle selected from imidazolyl, triazolyl, tetrazolyl and pyridinyl;is an optionally substituted unsaturated mono- or bicyclic heterocycle; and aryl is optionally substituted phenyl. The present invention also relates to processes for their preparation and compositions comprising said new compounds, as well as their use as a medicine.
申请公布号 US6833375(B2) 申请公布日期 2004.12.21
申请号 US20020238686 申请日期 2002.09.10
申请人 JANSSEN PHARMACEUTICA, N.V. 发明人 VENET MARC GASTON;MABIRE DOMINIQUE JEAN-PIERRE;LACRAMPE JEAN FERNAND ARMAND;SANZ GERARD CHARLES
分类号 C07D473/34;A61K31/00;A61K31/41;A61K31/415;A61K31/4164;A61K31/4184;A61K31/42;A61K31/423;A61K31/425;A61K31/427;A61K31/435;A61K31/4353;A61K31/437;A61K31/44;A61K31/4427;A61K31/4439;A61K31/445;A61K31/4465;A61K31/4523;A61K31/454;A61K31/47;A61K31/472;A61K31/4725;A61K31/495;A61K31/496;A61K31/4965;A61K31/497;A61K31/498;A61K31/50;A61K31/501;A61K31/502;A61K31/505;A61K31/506;A61K31/517;A61K31/519;A61K31/52;A61K31/529;A61K31/535;A61K31/5375;A61K31/5377;A61P17/00;A61P17/06;A61P35/00;A61P43/00;C07D277/22;C07D401/12;C07D403/12;C07D413/12;C07D417/12;C07D513/04;C07D521/00;(IPC1-7):C07D417/10;C07D277/60;A61K31/422;A61K31/426 主分类号 C07D473/34
代理机构 代理人
主权项
地址